Health Insurance Stocks Surge on Medicare News
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy AAPL?
Source: Fool
- Medicare Spending Boost: The Trump administration's announcement of a 2.48% increase in Medicare Advantage payments for 2027, significantly higher than the previously proposed 0.09%, led to a surge in health insurance stocks, with UnitedHealth rising nearly 8% in early trading.
- CVS and Humana Rebound: CVS Health's stock jumped close to 7%, while Humana surged over 11% on the news, despite being down 29% year-to-date, indicating a strong market reaction to the increased Medicare spending.
- Apple Foldable Phone Issues: Apple faces technical challenges in the engineering test phase of its new foldable iPhone, potentially delaying its launch scheduled for the second half of 2026, although its stock remained largely unchanged in early trading.
- Broadcom AI Partnerships: Broadcom has signed a deal with Google to produce AI chips through 2031 and will provide AI startup Anthropic with 3.5 gigawatts of computing capacity, resulting in a 3% rise in its stock during pre-market trading.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AAPL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AAPL
Wall Street analysts forecast AAPL stock price to rise
27 Analyst Rating
17 Buy
9 Hold
1 Sell
Moderate Buy
Current: 258.860
Low
239.00
Averages
306.89
High
350.00
Current: 258.860
Low
239.00
Averages
306.89
High
350.00
About AAPL
Apple Inc. designs, manufactures and markets smartphones, personal computers, tablets, wearables and accessories, and sells a variety of related services. Its product categories include iPhone, Mac, iPad, and Wearables, Home and Accessories. Its software platforms include iOS, iPadOS, macOS, watchOS, visionOS, and tvOS. Its services include advertising, AppleCare, cloud services, digital content and payment services. The Company operates various platforms, including the App Store, that allow customers to discover and download applications and digital content, such as books, music, video, games and podcasts. It also offers digital content through subscription-based services, including Apple Arcade, Apple Fitness+, Apple Music, Apple News+, and Apple TV+. Its products include iPhone 16 Pro, iPhone 16, iPhone 15, iPhone 14, iPhone SE, MacBook Air, MacBook Pro, iMac, Mac mini, Mac Studio, Mac Pro, iPad Pro, iPad Air, AirPods, AirPods Pro, AirPods Max, Apple TV, Apple Vision Pro and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Revenue Growth Analysis: According to UBS, Apple's (AAPL) App Store revenue increased by 7% year-over-year in Q1 2026, although the growth was only about 80 basis points higher than the previous quarter, indicating a slowdown in momentum.
- FX Impact: On a foreign exchange neutral basis, the App Store's growth was approximately 5% in Q1 2026, consistent with Q4 2025, highlighting the significant supportive role of FX factors on revenue.
- Future Outlook: Looking ahead to the June 2026 quarter, Apple's revenue growth expectation is around 12%, essentially unchanged from the previous quarter, indicating stability in future growth despite increasing competitive pressures.
- Regional Performance Disparity: The App Store revenue in the U.S. was essentially flat year-over-year, down roughly 320 basis points, while the rest of the world saw about 11% year-over-year growth, showcasing strong performance in international markets.
See More
- Buffett's Investment Reflection: In a recent interview, Buffett stated he sold his Apple shares 'too soon,' even though Apple remains Berkshire's largest holding at approximately 23%, indicating his ongoing confidence in the company.
- Apple Stake Changes: Berkshire has gradually reduced its Apple stake over the past few years, which once accounted for 40% of its portfolio, and this trimming strategy may be aimed at balancing investment risks.
- Market Response and Outlook: Despite Apple’s stock price declining over 6% in the past year, the support from Buffett and new CEO Abel suggests that Apple still has potential for growth, particularly with its developments and partnerships in the AI sector.
- Shareholder Return Strategy: Apple is expected to continue returning substantial capital to shareholders while maintaining a strong moat in its device ecosystem, prompting investors to consider following Buffett's advice to buy the stock in the current market environment.
See More
- Market Opportunity: MP Materials operates the only large-scale rare earth mining site in the U.S. at Mountain Pass, crucial for supply chain security as China is projected to dominate 69% of global rare earth production by 2025, highlighting MP's strategic importance.
- Strategic Investment: The U.S. government has entered a $400 million partnership with MP Materials, guaranteeing a price floor of $110 per kilogram for its core product, neodymium-praseodymium, which not only provides capital but also enhances its competitive position in the market.
- Future Capacity Expansion: MP plans to open its second magnet factory in 2028, with an expected output of 10,000 metric tons per year, aligning with U.S. magnet consumption needs projected to exceed 20,000 metric tons by 2028 and 50,000 metric tons by 2035.
- Valuation Analysis: Currently, MP Materials has a market valuation of approximately $9 billion against $225 million in annual revenue, and with a forward P/E ratio of 1,430, the market's high expectations for its future performance necessitate caution from investors despite its long-term growth potential.
See More
- Rare Earth Supply Chain Policy: MP Materials is benefiting from the U.S. government's push for a domestic rare earth supply chain, with its second magnet factory expected to produce 10,000 metric tons annually by 2028, meeting U.S. magnet consumption needs for 2024.
- Market Opportunity Analysis: With a market valuation of approximately $9 billion based on $225 million in revenue over the past 12 months, MP Materials shows long-term growth potential despite its current stock price nearing $50, especially as demand for rare earth elements continues to rise.
- Strategic Partnership Agreement: The partnership with Apple includes a $400 million investment and a guaranteed price floor of $110 per kilogram for neodymium-praseodymium, providing financial backing for MP Materials' expansion and ensuring competitiveness in the future market.
- Future Growth Expectations: By 2035, U.S. demand for magnets is projected to exceed 50,000 metric tons, and if MP Materials can meet this demand, its market position will significantly strengthen, although the current high valuation implies increased risk.
See More
- Apple Performance: Evercore ISI reiterates Apple as outperform despite slowing App Store growth, expecting AAPL to compensate through higher growth areas like Apple Pay, iCloud, and Licensing, with a target price of $330.
- Homebuilders Downgrade: Seaport downgrades Toll Brothers and D.R. Horton to neutral, anticipating a 15% downside due to ongoing demand pressures and book valuations below 2013 levels.
- MercadoLibre Investment Upgrade: Jefferies upgrades MercadoLibre from hold to buy, citing its growth investment strategy in Latin America as a driver for long-term growth.
- Rocket Lab Rating Upgrade: Citizens upgrades Rocket Lab from market perform to market outperform with an $85 price target, highlighting its favorable positioning in the space economy and improved risk/reward dynamics.
See More
- Medicare Spending Boost: The Trump administration's announcement of a 2.48% increase in Medicare Advantage payments for 2027, significantly higher than the previously proposed 0.09%, led to a surge in health insurance stocks, with UnitedHealth rising nearly 8% in early trading.
- CVS and Humana Rebound: CVS Health's stock jumped close to 7%, while Humana surged over 11% on the news, despite being down 29% year-to-date, indicating a strong market reaction to the increased Medicare spending.
- Apple Foldable Phone Issues: Apple faces technical challenges in the engineering test phase of its new foldable iPhone, potentially delaying its launch scheduled for the second half of 2026, although its stock remained largely unchanged in early trading.
- Broadcom AI Partnerships: Broadcom has signed a deal with Google to produce AI chips through 2031 and will provide AI startup Anthropic with 3.5 gigawatts of computing capacity, resulting in a 3% rise in its stock during pre-market trading.
See More










